Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

DNA demethylation in normal colon tissue predicts predisposition to multiple cancers

Abstract

Some colon cancer (CC) patients present synchronous cancers at diagnosis and others develop metachronous neoplasms, but the risk factors are unclear for non-hereditary CC. We showed previously that global DNA demethylation increased with aging and correlated with genomic damage in CC, and we show now that preferentially associates to CCs with wild-type p53. This study aimed to elucidate the extent of DNA hypomethylation in patients with single and multiple CC, its relationship with aging, and its potential as predictive tool. We compared by real-time methylation-specific PCR the relative demethylation level (RDL) of long interspersed nucleotide element-1 (LINE-1) sequences in matched cancer tissues and non-cancerous colonic mucosa (NCM) from patients with single and multiple right-sided CCs. Although no RDL difference was found in NCM from single CC patients and healthy volunteers (P=0.5), there was more demethylation (higher RDL) in NCM from synchronous cancer patients (P=1.1 × 10−5) multiple CCs also were more demethylated than single CCs (P=0.0014). High NCM demethylation was predictive for metachronous neoplasms (P=0.003). In multivariate logistic regression analyses RDL was the only independent predictor for metachronous (P=0.02) and multiple (P=4.9 × 10−5) tumors. The higher LINE-1 demethylation in NCM from patients with multiple (synchronous and metachronous) tumors (P=9.6 × 10−7) was also very significant in patients with tumors without (P=3.8 × 10−6), but not with (P=0.16) microsatellite instability. NCM demethylation increased with aging in patients with single tumors, but decreased in those with multiple tumors. Moreover, the demethylation difference between patients with single vs multiple tumors appeared higher in younger (P=3.6 × 10−4) than in older (P=0.0016) patients. These results predict that LINE-1 hypomethylation in NCM can be used as an epigenetic predictive biomarker for multiple CC risk. The stronger association of demethylation in NCM with multiple CC risk from younger patients also suggests an inherited predisposition for the apparent field cancerization effect of somatic demethylation.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Bouvier AM, Latournerie M, Jooste V, Lepage C, Cottet V, Faivre J . The lifelong risk of metachronous colorectal cancer justifies long-term colonoscopic follow-up. Eur J Cancer 2008; 44: 522–527.

    Article  Google Scholar 

  2. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993; 104: 1535–1549.

    Article  CAS  Google Scholar 

  3. Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2006; 130: 1865–1871.

    Article  Google Scholar 

  4. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH . A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63: 1727–1730.

    CAS  PubMed  Google Scholar 

  5. Slaughter DP, Southwick HW, Smejkal W . Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963–968.

    Article  CAS  Google Scholar 

  6. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS . Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996; 274: 2057–2059.

    Article  CAS  Google Scholar 

  7. Ahlquist T, Lind GE, Costa VL, Meling GI, Vatn M, Hoff GS et al. Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. Mol Cancer 2008; 7: 94.

    Article  Google Scholar 

  8. Belshaw NJ, Pal N, Tapp HS, Dainty JR, Lewis MP, Williams MR et al. Patterns of DNA methylation in individual colonic crypts reveal aging and cancer-related field defects in the morphologically normal mucosa. Carcinogenesis 2010; 31: 1158–1163.

    Article  CAS  Google Scholar 

  9. Konishi K, Shen L, Jelinek J, Watanabe Y, Ahmed S, Kaneko K et al. Concordant DNA methylation in synchronous colorectal carcinomas. Cancer Prev Res (Phila) 2009; 2: 814–822.

    Article  CAS  Google Scholar 

  10. Menigatti M, Truninger K, Gebbers JO, Marbet U, Marra G, Schar P . Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters. Oncogene 2009; 28: 899–909.

    Article  CAS  Google Scholar 

  11. Paun BC, Kukuruga D, Jin Z, Mori Y, Cheng Y, Duncan M et al. Relation between normal rectal methylation, smoking status, and the presence or absence of colorectal adenomas. Cancer 2010; 116: 4495–4501.

    Article  Google Scholar 

  12. Ushijima T . Epigenetic field for cancerization. J Biochem Mol Biol 2007; 40: 142–150.

    CAS  PubMed  Google Scholar 

  13. Worthley DL, Whitehall VL, Buttenshaw RL, Irahara N, Greco SA, Ramsnes I et al. DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene 2010; 29: 1653–1662.

    Article  CAS  Google Scholar 

  14. Svrcek M, Buhard O, Colas C, Coulet F, Dumont S, Massaoudi I et al. Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers. Gut 2010; 59: 1516–1526.

    Article  CAS  Google Scholar 

  15. Gonzalo V, Lozano JJ, Munoz J, Balaguer F, Pellise M, Rodriguez de Miguel C et al. Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. PLoS One 2010; 5: e8777.

    Article  Google Scholar 

  16. Feinberg AP, Vogelstein B . Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89–92.

    Article  CAS  Google Scholar 

  17. Feinberg AP, Tycko B . The history of cancer epigenetics. Nat Rev Cancer 2004; 4: 143–153.

    Article  CAS  Google Scholar 

  18. Eden A, Gaudet F, Waghmare A, Jaenisch R . Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300: 455.

    Article  CAS  Google Scholar 

  19. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW et al. Induction of tumors in mice by genomic hypomethylation. Science 2003; 300: 489–492.

    Article  CAS  Google Scholar 

  20. Kawakami K, Matsunoki A, Kaneko M, Saito K, Watanabe G, Minamoto T . Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer. Cancer Sci 2011; 102: 166–174.

    Article  CAS  Google Scholar 

  21. Sunami E, de Maat M, Vu A, Turner RR, Hoon DS . LINE-1 hypomethylation during primary colon cancer progression. PLoS One 2011; 6: e18884.

    Article  CAS  Google Scholar 

  22. Ibrahim AE, Arends MJ, Silva AL, Wyllie AH, Greger L, Ito Y et al. Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression. Gut 2011; 60: 499–508.

    Article  CAS  Google Scholar 

  23. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES et al. A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 2008; 100: 1734–1738.

    Article  CAS  Google Scholar 

  24. Yamashita K, Dai T, Dai Y, Yamamoto F, Perucho M . Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 2003; 4: 121–131.

    Article  CAS  Google Scholar 

  25. Suzuki K, Suzuki I, Leodolter A, Alonso S, Horiuchi S, Yamashita K et al. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 2006; 9: 199–207.

    Article  CAS  Google Scholar 

  26. Suter CM, Martin DI, Ward RL . Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int J Colorectal Dis 2004; 19: 95–101.

    Article  Google Scholar 

  27. Horii J, Hiraoka S, Kato J, Harada K, Kuwaki K, Fujita H et al. Age-related methylation in normal colon mucosa differs between the proximal and distal colon in patients who underwent colonoscopy. Clin Biochem 2008; 41: 1440–1448.

    Article  CAS  Google Scholar 

  28. Nosho K, Kure S, Irahara N, Shima K, Baba Y, Spiegelman D et al. A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology 2009; 137: 1609–1620, e1–3.

    Article  CAS  Google Scholar 

  29. Suzuki K, Ohnami S, Tanabe C, Sasaki H, Yasuda J, Katai H et al. The genomic damage estimated by arbitrarily primed PCR DNA fingerprinting is useful for the prognosis of gastric cancer. Gastroenterology 2003; 125: 1330–1340.

    Article  CAS  Google Scholar 

  30. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005; 33: 6823–6836.

    Article  CAS  Google Scholar 

  31. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M . Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363: 558–561.

    Article  CAS  Google Scholar 

  32. Vilar E, Gruber SB . Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol 2010; 7: 153–162.

    Article  CAS  Google Scholar 

  33. Estecio MR, Gharibyan V, Shen L, Ibrahim AE, Doshi K, He R et al. LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One 2007; 2: e399.

    Article  Google Scholar 

  34. Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U . Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840 149 screening colonoscopies. Gut 2007; 56: 1585–1589.

    Article  Google Scholar 

  35. Ehrlich M . DNA methylation in cancer: too much, but also too little. Oncogene 2002; 21: 5400–5413.

    Article  CAS  Google Scholar 

  36. Qu GZ, Grundy PE, Narayan A, Ehrlich M . Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet Cytogenet 1999; 109: 34–39.

    Article  CAS  Google Scholar 

  37. Xu GL, Bestor TH, Bourc’his D, Hsieh CL, Tommerup N, Bugge M et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999; 402: 187–191.

    Article  CAS  Google Scholar 

  38. Zeimet AG, Fiegl H, Goebel G, Kopp F, Allasia C, Reimer D et al. DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer. Gynecol Oncol 2011; 121: 24–31.

    Article  CAS  Google Scholar 

  39. Umar A, Risinger JI, Hawk ET, Barrett JC . Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 2004; 4: 153–158.

    Article  CAS  Google Scholar 

  40. Kim H, Jen J, Vogelstein B, Hamilton SR . Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994; 145: 148–156.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Thibodeau SN, Bren G, Schaid D . Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816–819.

    Article  CAS  Google Scholar 

  42. Perucho M . Cancer of the microsatellite mutator phenotype. Biol Chem 1996; 377: 675–684.

    CAS  PubMed  Google Scholar 

  43. Tsao JL, Yatabe Y, Salovaara R, Jarvinen HJ, Mecklin JP, Aaltonen LA et al. Genetic reconstruction of individual colorectal tumor histories. Proc Natl Acad Sci USA 2000; 97: 1236–1241.

    Article  CAS  Google Scholar 

  44. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2009.

Download references

Acknowledgements

This work was supported in part by grants from the Ministry of Education, Culture, Science, Sports, and Technology of Japan, NIH grant R37 CA63585 and from the Spanish Ministry of Science and Innovation (FIS PI09/02444).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to K Suzuki or M Perucho.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kamiyama, H., Suzuki, K., Maeda, T. et al. DNA demethylation in normal colon tissue predicts predisposition to multiple cancers. Oncogene 31, 5029–5037 (2012). https://doi.org/10.1038/onc.2011.652

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2011.652

Keywords

This article is cited by

Search

Quick links